<!-- received="Fri Jul  2 17:02:51 1999 MDT" -->
<!-- sent="Fri, 2 Jul 1999 16:02:42 -0700 (PDT)" -->
<!-- name="Doug Skrecky" -->
<!-- email="oberon@vcn.bc.ca" -->
<!-- subject="glutamine prevents heart damage" -->
<!-- id="Pine.GSO.4.10.9907021602120.22280-100000@vcn.bc.ca" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=35 -->
<html><head><title>extropians: glutamine prevents heart damage</title>
<meta name=author content="Doug Skrecky">
<link rel=author rev=made href="mailto:oberon@vcn.bc.ca" title ="Doug Skrecky">
</head><body>
<h1>glutamine prevents heart damage</h1>
Doug Skrecky (<i>oberon@vcn.bc.ca</i>)<br>
<i>Fri, 2 Jul 1999 16:02:42 -0700 (PDT)</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#81">[ date ]</a><a href="index.html#81">[ thread ]</a><a href="subject.html#81">[ subject ]</a><a href="author.html#81">[ author ]</a>
<!-- next="start" -->
<li><a href="0082.html">[ Next ]</a><a href="0080.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
<!-- body="start" -->

<p>
Authors
<br>
  Khogali SE.  Harper AA.  Lyall JA.  Rennie MJ.
Institution
<br>
  Department of Anatomy &amp; Physiology, University of Dundee, Scotland, UK.
Title
<br>
  Effects of L-glutamine on
<br>
  post-ischaemic cardiac function: protection and rescue.
Source
<br>
  Journal of Molecular &amp; Cellular Cardiology.  30(4):819-27, 1998 Apr.
Abstract
<br>
  We investigated the effects of L-glutamine
<br>
  (0-20 mM) on cardiac function. The isolated perfused working rat heart (left<br>
  atrial and aortic pressures of 5 and 70 cm H2O, respectively) was subjected
  to 20 min of normothermic low-flow ischaemia followed by reperfusion for 35
  min. In the absence of glutamine, ischaemia-reperfusion caused an immediate
  significant (P &lt; 0.01) fall in cardiac output from 46 to 20 ml/min, with a
  further deterioration to 17 ml/min at 35 min reperfusion. Ischaemia also
  caused a significant (P &lt; 0.05) fall in myocardial glutamate from 2.6 to 1.8
  mumol/g wet weight; and ischaemia-reperfusion caused significant (each P &lt;
  0.05) diminutions of myocardial ATP from 3.5 to 1.0 mumol/g wet weight and
  phosphocreatine from 4.8 to 1.5 mumol/g wet weight and resulted in
  significant (P &lt; 0.05) accumulation of myocardial lactate from 0.9 to 4.3
  mumol/g wet weight. Glutamine, present throughout the perfusion protocol
<br>
  (i.e. prior to ischaemia), at or above 1.25 mM, prevented the<br>
  post-ischaemic diminution of cardiac output and the
  deleterious changes in myocardial metabolites.
  Post-ischaemic treatment with glutamine at 2.5 mM completely
  prevented the post-ischaemic diminution of cardiac output
  and restored the myocardial metabolites to normal. CONCLUSIONS: Glutamine may
  be suitable as a cardioprotective and rescue agent. These
  effects may be mediated by maintenance of myocardial
  glutamate, ATP and phosphocreatine: and prevention of lactate accumulation.
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="0082.html">[ Next ]</a><a href="0080.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
</body></html>
